TRIA Beauty Inc. hopes to enter the anti-aging aesthetic treatment market later this year with its over-the-counter Skin Rejuvenating Laser, supported in part with the proceeds of an initial public stock offering worth up to $86.3 million.
The firm plans to file a 510(k) this year for OTC use of the fractional, non-ablative technology to treat periorbital wrinkles, perioral wrinkles, dyschromia and textural irregularities like tactile roughness, according to a Jan
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?